Social News XYZ     

Zydus Cadila’s anti-depressant drug gets US regulatory nod

Posted By: Doraiah Vundavally October 7, 2017

Zydus Cadila's anti-depressant drug gets US regulatory nodMumbai, Oct 7 (IANS) Pharmaceuticals major Zydus Cadila on Saturday said it received approval from the US Federal Drug Authority (USFDA) to market Amitriptyline Hydrochloride tablets for the treatment of depression.

According to the drugs major, it has received approval to market the tablets in strengths of 10 mg, 25 mg, 50 mg, 100 mg and 150 mg.

"The drug is used to treat depression and will be manufactured at the group's formulation facility at SEZ, Ahmedabad," said the company in a regulatory filing to the BSE.

 

The group now has more than 160 approvals and has so far filed over 300 Abbreviated New Drug Applications (ANDAs) since the commencement of the company's filing process.

(This story has not been edited by Social News XYZ staff and is auto-generated from a syndicated feed.)

Facebook Comments
Zydus Cadila's anti-depressant drug gets US regulatory nod

About VDC

Doraiah Chowdary Vundavally is a Software engineer at VTech . He is the news editor of SocialNews.XYZ and Freelance writer-contributes Telugu and English Columns on Films, Politics, and Gossips. He is the primary contributor for South Cinema Section of SocialNews.XYZ. His mission is to help to develop SocialNews.XYZ into a News website that has no bias or judgement towards any.